Bottom line
IDEV vs BBIN: the short answer
IDEV (iShares Core MSCI International Developed Markets ETF) and BBIN (JPMorgan BetaBuilders International Equity ETF) have nearly the same top holdings — their top 25 positions are about 86% the same by weight.
But IDEV is far broader, holding 2,337 positions to 643 for BBIN, so beyond the top names it adds exposure BBIN doesn't have.
IDEV is cheaper at 0.04% vs 0.07% — a difference of $3.00 a year per $10,000 invested.
Over five years, BBIN returned +9.1% a year vs +5.0% for IDEV (reporting dates differ).
Updated Nov 19, 2026
IDEV vs BBIN side by side
| IDEV | BBIN | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | J.P. Morgan |
| Category | International Stock | International Stock |
| Expense ratio | 0.04% | 0.07% |
| Annual cost per $10k | $4 | $7 |
| 10-yr cost on $10k (prospectus) | $51 | $90 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +4.5% | +32.1% |
| 5-yr return (annualized) | +5.0% | +9.1% |
| 10-yr return (annualized) | — | — |
| Best quarter | +16.9% | +18.3% |
| Worst quarter | −24.0% | −23.1% |
| Net assets (fund) | $31.6B | $6.6B |
| Number of holdings | 2,337 | 643 |
| Portfolio turnover | 3% | 5% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IDEV | BBIN | Difference |
|---|---|---|---|
| 2024 | +4.5% | +3.5% | +1.0% |
| 2023 | +17.3% | +18.2% | −0.9% |
| 2022 | −14.9% | −14.1% | −0.8% |
| 2021 | +12.7% | +11.4% | +1.3% |
| 2020 | +8.4% | +8.6% | −0.2% |
Source: Fund prospectus bar charts
Holdings overlap
19 of IDEV's top 25 holdings also appear in BBIN's top 25.
| Holding | IDEV | BBIN |
|---|---|---|
| ASML Holding N.V. | 2.19% | 2.93% |
| Hsbc Holdings Plc | 1.24% | 1.68% |
| Roche Holding AG | 1.05% | 1.38% |
| Novartis AG | 0.98% | 1.37% |
| Astrazeneca Plc | 0.88% | 1.21% |
| Nestle S.A. | 0.88% | 1.14% |
| Shell Plc | 0.88% | 1.17% |
| Mitsubishi UFJ Financial Group, Inc. | 0.82% | 1.16% |
| Commonwealth Bank Of Australia | 0.72% | 0.96% |
| Banco Santander, S.A. | 0.70% | 0.93% |
| Sap Se | 0.65% | 0.86% |
| Allianz SE | 0.65% | 0.87% |
| Schneider Electric Se | 0.63% | 0.83% |
| Totalenergies Se | 0.59% | 0.85% |
| UBS Group AG | 0.57% | 0.72% |
Source: SEC Form N-PORT
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
BBIN top 10
- ASML Holding NV — 2.93%
- HSBC Holdings plc — 1.68%
- Roche Holding AG — 1.38%
- Novartis AG — 1.37%
- AstraZeneca plc — 1.21%
- Shell plc — 1.17%
- Mitsubishi UFJ Financial Group, Inc. — 1.16%
- Nestle SA — 1.14%
- Siemens AG — 1.07%
- Toyota Motor Corp. — 0.99%
FAQ
What is the difference between IDEV and BBIN?
Which is cheaper, IDEV or BBIN?
Should I own both IDEV and BBIN?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.